Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
Key physiological functions of the liver, including glucose and lipid metabolism, become
disturbed in the setting of non-alcoholic fatty liver disease (NAFLD) and may be associated …
disturbed in the setting of non-alcoholic fatty liver disease (NAFLD) and may be associated …
Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications
C Palombo, M Kozakova - Vascular pharmacology, 2016 - Elsevier
Arterial stiffness results from a degenerative process affecting mainly the extracellular matrix
of elastic arteries under the effect of aging and risk factors. Changes in extracellular matrix …
of elastic arteries under the effect of aging and risk factors. Changes in extracellular matrix …
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Chronic liver disease (CLD) is associated with approximately two million annual deaths
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
NAFLD is a spectrum of progressive liver disease that encompasses simple steatosis,
NASH, fibrosis and, ultimately, cirrhosis. NAFLD is recognized as the hepatic component of …
NASH, fibrosis and, ultimately, cirrhosis. NAFLD is recognized as the hepatic component of …
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
Non-alcoholic fatty liver disease is marked by hepatic fat accumulation not due to alcohol
abuse. Several studies have demonstrated that NAFLD is associated with insulin resistance …
abuse. Several studies have demonstrated that NAFLD is associated with insulin resistance …
Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases
Cardiovascular diseases (CVDs) remain a leading cause of death worldwide. Among the
major risk factors for CVD, obesity and diabetes mellitus have received considerable …
major risk factors for CVD, obesity and diabetes mellitus have received considerable …
[HTML][HTML] From NAFLD in clinical practice to answers from guidelines
F Nascimbeni, R Pais, S Bellentani, CP Day… - Journal of …, 2013 - Elsevier
This review of the literature consists of three sections. First, papers concerning non-alcoholic
fatty liver disease (NAFLD) awareness among the general population, general practitioners …
fatty liver disease (NAFLD) awareness among the general population, general practitioners …
Localization of fat depots and cardiovascular risk
O Gruzdeva, D Borodkina, E Uchasova… - Lipids in health and …, 2018 - Springer
Despite the existing preventative and therapeutic measures, cardiovascular diseases
remain the main cause of temporary disability, long-term disability, and mortality. Obesity is a …
remain the main cause of temporary disability, long-term disability, and mortality. Obesity is a …
Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease
G Ndrepepa, R Colleran, A Kastrati - Clinica chimica acta, 2018 - Elsevier
Gamma-glutamyl transferase (GGT) is a ubiquitous cell surface enzyme that cleaves
extracellular glutathione (G-SH) or other gamma-glutamyl compounds. GGT serves to …
extracellular glutathione (G-SH) or other gamma-glutamyl compounds. GGT serves to …
the diagnosis of non‐alcoholic fatty liver disease–availability and accuracy of non‐invasive methods
D Festi, R Schiumerini, L Marzi… - Alimentary …, 2013 - Wiley Online Library
Background Non‐alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of
clinical conditions, actually representing an emerging disease of great clinical interest …
clinical conditions, actually representing an emerging disease of great clinical interest …